AAD Licensed Content

Dr. Sandy Tsao reviewed recent cosmetic and laser advances, beginning with GLP-1–associated facial volume loss and skin laxity seen after major weight loss. She emphasized that early intervention with…

Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Cosmetic and Laser Updates: GLP-1 Facial Changes, Biostimulatory Fillers, Microcoring, and Emerging Treatments

Description

Dr. Sandy Tsao reviewed recent cosmetic and laser advances, beginning with GLP-1–associated facial volume loss and skin laxity seen after major weight loss. She emphasized that early intervention with hyaluronic acid fillers plus biostimulatory agents such as poly-L-lactic acid or calcium hydroxylapatite can help preserve contour, improve skin quality, and support regenerative collagen formation. She then discussed poly-L-lactic acid as a long-used biostimulator now applied beyond the face to the neck, chest, buttocks, arms, knees, and abdomen in hyperdilute form, with results lasting years. A newer dermal microcoring device was presented as a minimally invasive option for moderate-to-severe wrinkles and some skin tightening, though technique matters and scarring can still occur. The talk also highlighted expanding uses of botulinum toxin: a liposomal cream for hyperhidrosis, toxin injections for Raynaud’s phenomenon and Hailey-Hailey disease, hyaluronidase for microstomia in systemic sclerosis, and botulinum toxin E as a fast-on, short-duration neurotoxin useful for event-based or first-time patients. Finally, she described microdroplet botulinum toxin for facial slimming, seborrhea, rosacea, and enlarged pores, and ultrasound-based therapy for skin tightening and acne scar improvement, stressing that many newer approaches aim to combine efficacy, safety, and regenerative outcomes.

View more

Conclusions

  • GLP-1–associated weight loss can produce noticeable facial volume loss and skin laxity, so early intervention with fillers and biostimulatory agents may help patients maintain a more natural appearance while continuing treatment.
  • Combined hyaluronic acid and poly-L-lactic acid regimens appear to improve facial contour, skin thickness, hydration, radiance, and patient satisfaction in people using GLP-1 medications.
  • Poly-L-lactic acid is emerging as a regenerative biostimulator not only for the face but also for off-face body areas such as the neck, chest, buttocks, arms, knees, and abdomen, with benefits that may last for years.
  • Dermal microcoring can meaningfully reduce moderate facial wrinkles and some body laxity, but its benefits are technique-dependent and it may still cause visible grid-pattern scarring, so it is not entirely scarless.
  • Botulinum toxin has expanded beyond wrinkle treatment and can be useful for hyperhidrosis, Raynaud phenomenon, Hailey-Hailey disease, seborrhea, rosacea, and enlarged pores.
  • Topical liposomal botulinum toxin may offer a less invasive alternative for axillary hyperhidrosis, but injectables still provide a more established effect.
  • Botulinum toxin A can improve Raynaud symptoms, finger warmth, ulcer healing, and swelling, suggesting a real vascular and symptomatic benefit in selected patients.
  • Perilesional botulinum toxin A can reduce pain and lesions in Hailey-Hailey disease, and lasers may provide longer remissions in more severe cases.
  • Perioral hyaluronidase injections can improve microstomia in systemic sclerosis, increasing oral aperture and function in a way that patients may find life-changing.
  • Botulinum toxin E introduces a new cosmetic neurotoxin option with very rapid onset and very short duration, making it especially attractive for first-time or event-based users who want temporary results.
  • Microdroplet botulinum toxin techniques may provide modest lifting effects and can improve seborrhea, acne, rosacea redness, and facial pore size when placed superficially and carefully.
  • Microcoring may also be useful for enlarged pores, offering a more durable but procedure-based alternative to microbotox.
  • Ultrasound-based skin tightening is a safe non-surgical option for mild to moderate laxity because it targets deeper tissues while sparing the epidermis and working across skin types.
  • High-intensity parallel ultrasound shows promise for acne atrophic scars by stimulating collagen remodeling with minimal downtime, broad skin-type applicability, and strong early safety and improvement signals.
  • Aesthetic Surgery Journal 2025, Vol 00(0) 1–11.
  • Aesthetic Plastic Surgery, 2024. DOI mentioned.
  • Plastic and Reconstructive Surgery Global Open, published online October 2022.#10.1097/gox.0b013e31828e2fc7
  • DERMATOLOGIC SURGERY 2024.
  • Australasian Journal of Dermatology (2018), Charlton, Stewart, and Rosen.
  • Journal of the American Academy of Dermatology retrospective cohort study.
  • Toxins 2021, 13, 817.
  • The Journal of Clinical and Aesthetic Dermatology, article on botulinum toxin for flushing and persistent erythema in rosacea.
  • Facial Plastic Surgery Clinics of North America, 2023.
  • Dermatologic Surgery • August 2025 • Volume 51 • Number 8.